Search Login Register

3-(2,4-dimethoxybenzylidene)anabaseine Summary

Description: a nicotinic cholinergic agonist

Also Known As: DMXBA; GTS 21; GTS-21

Networked: 34 relevant articles (7 outcomes, 6 trials/studies) for this Bio-Agent

Key Diseases for which 3-(2,4-dimethoxybenzylidene)anabaseine is Relevant

  1. Inflammation : 1 outcome 1 study in 3 results
  2. Neurodegenerative Diseases (Neurodegenerative Disease) : 1 outcome in 3 results
  3. Endotoxemia : 1 outcome in 2 results
  4. Acute Lung Injury : 1 outcome in 1 result
  5. Tobacco Use Disorder (Nicotine Dependence) : 1 outcome in 1 result
Show All >>

Drugs Related to 3-(2,4-dimethoxybenzylidene)anabaseine

  1. Nicotinic Receptors (Nicotinic Acetylcholine Receptor)
  2. HMGB1 Protein (HMG1)
  3. Nicotine
  4. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
  5. Bupropion (Wellbutrin)
  6. Glucose (Dextrose)
  7. Bromocriptine (Parlodel)
  8. varenicline (Chantix)
  9. rimonabant
  10. reboxetine (Vestra)
Show All >>

Therapies Related to 3-(2,4-dimethoxybenzylidene)anabaseine

  1. Drug Therapy (Chemotherapy)
  2. Mechanical Ventilators (Ventilator)
  3. Intraperitoneal Injections

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.